Sociedad Española de Terapia Génica y Celular
  • Home
  • About us
    • About us
    • History
    • Board Information
    • Awards
      • Award winners
    • Legal & bylaws
  • Events
    • Events
    • Sponsorship
    • Ask-the-expert
    • Current congress
    • e-School
    • e-Seminars
    • Previous Events
    • Upcoming events
    • Frequently asked questions
  • Networking & community
    • Networking & community
    • Gene and cell therapy community heatmap
    • Introduction to the Forum
    • Latest news
    • Non ESGCT events
    • Jobs & Courses
    • Blog
    • Newsletter archive
    • National Gene and cell therapy societies
  • Policies & advocacy
    • Policies & advocacy
    • Regulatory information
      • GMP Guidelines
    • EMA guidance
    • ESGCT statements
    • Useful links
  • Public & Patients
    • Public & Patients
    • Gene and cell therapy education
      • Covid 19 vaccines
      • Gene therapy 101
        • Cell therapy basics
        • Different approaches
        • Gene therapy basics
        • Vectors 101
    • Patients perspective
    • Sites of interest
    • What is gene therapy
  • Membership
    • Membership
    • Become a member
    • General Assembly of Members
    • Human Gene Therapy
    • Membership benefits
Home

This week in gene and cell therapy - 31 May 2019

Gene and cell therapy headlines 27 May - 31 May


Promethera Biosciences Announces First-Dosing in Phase 2a Clinical Study Evaluating World’s First Liver Stem Cell Therapy in Late-Stage NASH Patients?

Clinical Trial Underway for a Natural Killer Cell Therapy

First-line therapy with donor-derived HCMV-specific T cells reduces persistent HCMV infection by promoting antiviral immunity after allogenic stem cell transplantation

SALL3 expression balance underlies lineage biases in human induced pluripotent stem cell differentiation?

European Commission kills billion-euro flagship concept

Account login

Create a secure accountJoin
Forgotten your details?

Sponsors

Diamond

Platinum

Gold

Silver

Bronze

Copyright © 2022 Sociedad Española de Terapia Génica y Celular Member Area Terms and Conditions user account Privacy Policy Cookies Terms and Conditions membership purchase Terms and Conditions congress registration Terms and Conditions abstract submission Terms and Conditions user account RSS feed Join us Follow us